Treatment for Axillary Folliculitis
For mild axillary folliculitis, start with topical clindamycin 1% solution/gel applied twice daily for 12 weeks, combined with gentle cleansing and loose-fitting cotton clothing. 1
Initial Management and Hygiene Measures
- Use gentle pH-neutral soaps with tepid water for cleansing the axilla, pat the skin dry after showering, and wear loose-fitting cotton clothing to reduce friction and moisture 1
- Avoid greasy creams in the affected area and manipulation of the skin to reduce risk of secondary infection 1
- These conservative measures alone may be sufficient for very mild cases 1
First-Line Topical Therapy
- Apply topical clindamycin 1% solution/gel twice daily for 12 weeks as first-line therapy for mild cases 1
- Topical corticosteroids of mild to moderate potency can be used short-term to reduce inflammation, but avoid prolonged use as they may cause skin atrophy 1
Systemic Antibiotics for Moderate to Severe Disease
When topical therapy fails after 4-6 weeks or for more widespread disease:
- Oral tetracycline 500 mg twice daily for 4 months is the recommended next step 1
- Alternative tetracyclines include doxycycline and minocycline, which are more effective than tetracycline but neither is superior to the other 1
- For patients who cannot take tetracyclines (pregnant women, children under 8 years), erythromycin or azithromycin can be used 1
Special Considerations for Axillary Location
The axilla is a high-risk area that warrants specific antibiotic coverage:
- For infections involving the axilla, cefoxitin or ampicillin-sulbactam are the agents of choice due to the mixed bacterial flora in this anatomic location 2
- This recommendation reflects the higher likelihood of mixed aerobic and anaerobic organisms in axillary infections 2
Refractory Cases
If no improvement occurs after 8-12 weeks of tetracycline therapy:
- Consider combination therapy with oral clindamycin 300 mg twice daily plus rifampicin 600 mg once daily for 10 weeks 1
- For localized lesions at risk of scarring, intralesional corticosteroids can provide rapid improvement in inflammation and pain 1
Management of Large Furuncles or Abscesses
- Incision and drainage is the recommended treatment for large furuncles and abscesses 2
- Gram stain and culture of pus from carbuncles and abscesses are recommended to guide antibiotic therapy 2
- The decision to add systemic antibiotics should be based on presence of systemic inflammatory response syndrome (SIRS) such as fever >38°C, tachycardia >90 bpm, tachypnea >24 breaths/min, or WBC >12,000 cells/µL 2
- An antibiotic active against MRSA is recommended for patients with abscesses who have markedly impaired host defenses or SIRS 2
Recurrent Folliculitis Protocol
For patients with recurrent axillary folliculitis:
- Obtain bacterial cultures early in the course of infection and treat with a 5-10 day course of an antibiotic active against the isolated pathogen 2, 1
- Consider a 5-day decolonization regimen including intranasal mupirocin twice daily, daily chlorhexidine washes, and daily decontamination of personal items such as towels, sheets, and clothes 2, 1
- Search for local causes such as hidradenitis suppurativa or foreign material 2
Monitoring and Culture Guidance
- Bacterial cultures should be obtained for recurrent or treatment-resistant cases to guide antibiotic selection 1
- Staphylococcus aureus is the most frequently detected infectious agent, and MRSA coverage with trimethoprim-sulfamethoxazole should be considered when suspected or confirmed 1
- Systemic antibiotic use should be limited to the shortest possible duration with re-evaluation at 3-4 months to minimize bacterial resistance 1
Common Pitfalls to Avoid
- Avoid using topical acne medications without dermatologist supervision as they may irritate and worsen the condition 1
- Avoid prolonged use of topical steroids as they may cause skin atrophy 1
- Do not pack wounds after incision and drainage, as this causes more pain without improving healing—simply covering with sterile gauze is preferred 2
- Aspiration of abscesses is not recommended as it is successful in only 25% of cases overall and <10% with MRSA infections 2